Ansell(OTC) ANSLY

Ansell Limited specializes in the creation, development, and production of protective solutions across various sectors. With a strong presence in the Healthcare and Industrial markets, Ansell provides essential products that cater to a diverse clientele globally.

Products and Services

• Healthcare segment offers surgical, examination, and sterile gloves
• Industrial segment focuses on hand and chemical protective apparel
• Products serve industries like automotive, chemical processing, and healthcare

Growth Outlook

• Revenue for Q2 2025 reached $1.03 billion, a significant increase
• Net income for Q2 2025 was $88.95 million, reflecting strong profitability
• Operating income margin improved to 13.6% in the latest quarter

Financial Highlights

• Trailing twelve months (TTM) revenue of $4.06 billion, showcasing consistent growth
• Dividend yield of 2.52%, indicating a commitment to returning value to shareholders
• Current ratio of 2.36, demonstrating strong liquidity position

Ansell Limited has established itself as a leader in protective solutions, with a diverse product range that meets the needs of various industries. The company's recent financial performance indicates robust growth, particularly in revenue and net income, which are essential metrics for potential investors. The strong operating income margin further highlights the company's efficiency in managing its operations. With a solid dividend yield, Ansell demonstrates its commitment to shareholder value, making it an attractive option for those interested in the healthcare and industrial sectors. The company's liquidity position, as indicated by the current ratio, suggests it is well-equipped to handle short-term obligations, reinforcing its financial stability.